Published in AIDS Weekly, February 4th, 2008
"Two hundred four HIV-infected participants with selfreported ART adherence < 85% from a total of 3818 participants screened were randomized into the trial. Potential participants were recruited for the main trial based on sexual risk criteria in Los Angeles, Milwaukee, New York, and San Francisco. The primary outcome of the intervention was a reduction in HIV transmission risk behaviors. Fifteen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.